PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of annrheumdAnnals of the Rheumatic DiseasesVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
Ann Rheum Dis. 2007 December; 66(12): 1672–1674.
PMCID: PMC2095304

Isolated knee monoarthritis heralding resectable non‐small‐cell lung cancer. A paraneoplastic syndrome not previously described

Abstract

Objective

To describe isolated knee monoarthritis as a paraneoplastic syndrome heralding non‐small cell lung cancer (NSCLC), and to discuss its clinical characteristics.

Methods

Clinical records of all consecutive, new outpatients with isolated knee monoarthritis observed from January 2000 to December 2005 were reviewed. A systematic review of Medline and Cochrane Library databases was performed to identify English‐language articles related to rheumatological paraneoplastic syndromes associated with NSCLC.

Results

Over 6 years, 6654 new outpatients with different rheumatic disorders were observed. Of these, 296 (4.4%) presented with isolated monoarthritis of the knee. In five out of 296 patients (1.7%) this feature represented the initial manifestation of NSCLC. All five patients were middle‐aged men, with a long history of heavy cigarette smoking, who had a non‐erosive, isolated knee monoarthritis, with mild articular fluid collection of non‐inflammatory type. NSCLC was resectable in all patients, and knee monoarthritis remitted with no relapse confirming its paraneoplastic nature. All five patients are in good condition after a median follow up of 41 months. The literature review revealed that paraneoplastic knee monoarthritis has not previously been reported.

Conclusion

Knee monoarthritis may in some cases represent a paraneoplastic syndrome heralding NSCLC at an early stage.

Small‐cell lung cancer (SCLC) is associated with various types of paraneoplastic syndromes in approximately 10–20% of cases.1,2 Paraneoplastic syndromes associated with non‐small‐cell lung cancer (NSCLC) are less frequent and variable, but of particular interest. Given its resistance to chemotherapy, the prognosis of NSCLC is strictly dependent on the possibility of surgical removal, its early detection is thus of great importance.3

Hypertrophic osteoarthropathy (HOA), observed in approximately 5% of patients, is the most frequent paraneoplastic syndrome associated with NSCLC.1,2

To the best of our knowledge, isolated knee monoarthritis not associated with HOA, as the presenting feature of NSCLC, has not previously been reported.

A review of the clinical records of all outpatients presenting with isolated knee monoarthritis observed over a 6‐year period revealed that this manifestation heralded NSCLC in five patients.

The aim of this study was to describe the clinical characteristics of these patients, and to discuss the differential diagnosis.

Patients and methods

Setting

The Rheumatology Unit of Prato, Tuscany, Italy, is a secondary referral centre that serves approximately 300 000 people living in the province of Prato and the surrounding industrial areas. Approximately 75% of patients are sent by their general practitioners, and the remainder are self referred.

Since January 2000, the demographic and clinical data of all new outpatients presenting with rheumatic manifestations were recorded in a computed individual chart.

Isolated knee monoarthritis was defined by the presence of a tender and swollen joint not associated with other rheumatic features at onset. Patients with this manifestation had a standardized diagnostic approach, including history, complete physical examination, arthrocentesis with synovial fluid analysis, laboratory examinations, including blood cell count with differential count, kidney and liver function tests, erythrocyte sedimentation rate, C‐reactive protein, calcemia, uric acid level, rheumatoid factor, Lyme serology, antinuclear antibodies, HLA‐B27 typing, radiological examination of the affected joint, and pelvis X‐rays to investigate sacroiliitis.

Articular inflammation signs such as joint swelling size, warmth, redness, and tenderness, were currently graded with a semiquantitative scale from 1 to 3 (1, mild; 2, moderate; 3, severe). The sum provided the final arthritis grading: mild, 1–4; moderate, 5–8, and severe, 9–12.

Patients were followed up by the same rheumatologist, and visits were scheduled every 4 months or less if needed.

Data extraction

The clinical records of all new, consecutive outpatients presenting with isolated knee monoarthritis from January 2000 to December 2005 were reviewed. The following data were extracted and imputed in an SPSS statistical package (SPSS Inc., Chicago, Illinois, USA): date of first visit, family history, presence of digital clubbing, HOA, pulmonary symptoms, cutaneous manifestations, symptoms and signs of neuropathy or myopathy, laboratory examinations, HLA B27 typing, synovial fluid analysis results, knee and pelvis radiographic findings, further examination useful for the final diagnosis, treatment, and follow‐up duration. The follow‐up was extended to December 2006.

Literature review

A review of the literature published between 1966 and December 2006 using Medline and Cochrane Library databases was performed crossing the following indexing terms: lung cancer, SCLC, NSCLC, rheumatic paraneoplastic syndromes, acute monoarthritis, hypertrophic osteoarthropathy, digital clubbing, carcinoma polyarthritis. Articles were selected if they focused on case reports, clinical series, reviews, and meta‐analyses of patients with NSCLC and musculoskeletal manifestations.

Results

Between January 2000 and December 2005, 296 out of 6654 new outpatients (4.4%) had isolated monoarthritis of the knee. The final diagnoses in this cohort are reported in table 11.

Table thumbnail
Table 1 Final diagnoses in 296 consecutive outpatients presenting with isolated knee monoarthritis observed over a 6‐year period

Isolated, non‐erosive knee monoarthritis represented the first symptom of occult NSCLC in five out 296 (1.7%) patients. Before the visit, they had taken non‐steroidal anti‐inflammatory drugs with an unsatisfactory response. As shown in table 22,, all patients were middle‐aged men, with a history of heavy cigarette smoking.

Table thumbnail
Table 2 Demographic and clinical characteristics of the five patients with knee monoarthritis and non small‐cell lung cancer

As summarized in table 33,, synovial fluid was of non‐inflammatory type in all, with negative cytology.

Table thumbnail
Table 3 Paraneoplastic knee monoarthritis: synovial fluid analysis results in five patients

The arthritis characteristics, the results of synovial fluid analysis, the absence of marked radiological signs of osteoarthritis or sacroiliitis, and also the history of cigarette smoking raised the suspicion of a possible paraneoplastic syndrome.

In all five patients, chest X‐rays were highly suggestive of a malignant lung neoplasm. Chest computed tomography, and histological examination of bronchoscopic biopsies confirmed the diagnosis of NSCLC. Staging excluded extrapulmonary diffusion,4 and the cancer was resectable in all cases.

Cancer and knee monoarthritis remitted with no flares in all patients over a median follow‐up of 41 months (range 19–72).

Discussion

A wide variety of paraneoplastic syndromes are usually associated with SCLC.1 NSCLC is almost exclusively associated with HOA.2 This condition, observed in less than 1% of SCLC and in approximately 5% of NSCLC,2 consists of digital clubbing, proliferative periostitis of the distal ends of long bones, and arthritis.5 Symptoms of HOA may precede those of the underlying neoplasm by as much as 18 months,5 and the arthritis is more often polyarticular, symmetrical, and painful, involving the knees, ankles, elbows, wrists, and the small joints of hands and feet.6 Synovial fluid is non‐inflammatory, with normal appearance, good viscosity, low leukocyte numbers, and low protein concentration.6 HOA parallels the course of the underlying lung cancer, and usually subsides in the case of successful resection.5

In this paper we described five men with NSCLC in whom the presenting clinical feature was acute, non‐erosive, asymmetric arthritis of the knee, not associated with systemic or pulmonary symptoms. The originality of this manifestation should be challenged with the possibility of an initial phase or an incomplete form of HOA. This option seems unlikely for at least two reasons: first, in contrast to our patients, joint involvement in HOA is predominantly polyarticular and symmetrical;5,6 second, the chronology of the clinical features of HOA is usually characterized by the onset of digital clubbing as the first manifestation, with periostitis and arthropathy occurring in a later phase.7 Clubbing was absent in all our patients, although this feature is frequently seen in association with NSCLC.7

Metastatic involvement of bone occurs in at least 20% of patients with NSCLC.2 Any bone can be affected, although the axial skeleton and proximal long bones are prevalently involved. Rarely, knee monoarthritis caused by adjacent bone metastases8,9,10 or direct synovial invasion has been described in patients with NSCLC.11 Synovial fluid analysis with negative cytology and the normality of radiographs and radionuclide scanning allowed the exclusion of this possibility in our patients.

In our 6‐year clinical series, isolated knee monoarthritis occurred in 4.4% of 6654 new outpatients. Osteoarthritis and other degenerative disorders of the knee were the most frequent causes, followed by other inflammatory diseases such as psoriatic arthritis and spondyloarthropathies, infectious and crystal‐related arthritis, and less frequent conditions including villonodular synovitis and emarthrosis. The simultaneous occurrence of psoriatic arthritis and lung cancer has recently been described.12 Moreover, some rheumatic disorders and related therapies are associated with a greater incidence of malignancies.13 Consequently, the possible coexistence of incidental NSCLC and asymmetric knee arthritis related to an antedating or concomitant cause other than a paraneoplastic one might explain the clinical picture in our patients. This possibility could, however, be ruled out for several reasons: all five patients had a negative family history of psoriasis and spondyloarthropathies, none of them had associated features suggesting spondyloarthropathy, all were HLA‐B27 negative, articular symptoms were of short duration, synovial fluid was non‐inflammatory, crystals were absent, cultures were negative, and knee radiographs were not indicative of severe osteoarthritis or chondrocalcinosis. Finally, confirming its paraneoplastic nature, after the surgical removal of the lung cancer, no flares of knee arthritis or other rheumatic manifestations occurred in our patients over a prolonged follow‐up.

In our 6‐year clinical series, paraneoplastic knee monoarthritis was not a remote event, being observed in 1.7% of all patients with isolated asymmetric arthritis of the knee. Notably, this clinical manifestation occurred at an early phase of NSCLC, at stages IA or IB, thus allowing the surgical resection of the tumour.14 NSCLC is diagnosed at these stages in only 45% of cases, with important positive repercussions on long‐term survival.15 In keeping with this statement, all five patients were disease‐free after a median follow‐up of 41 months.

Therefore, the most relevant clinical characteristics of paraneoplastic knee monoarthritis associated with NSCLC deserve to be emphasized. In our experience, this paraneoplastic condition should be suspected in all heavy smokers, HLA‐B27 negative, who present with mild to moderate isolated knee monoarthritis in the absence of a clear history of psoriasis or spondyloarthropathy, and of radiological features suggestive of severe osteoarthritis or chondrocalcinosis. Arthrocentesis with synovial fluid analysis is mandatory to confirm its non‐inflammatory nature, and to exclude other possible causes of joint fluid collection. As in our patients, when the most common causes of knee monoarthritis are ruled out, a chest radiograph is recommended as a first level investigation.

In conclusion, in our clinical series we detected five patients with paraneoplastic knee monoarthritis heralding NSCLC at an early stage. Although not frequent, awareness of the main clinical characteristics of this manifestation may help to facilitate proper diagnosis.

Abbreviations

HOA - Hypertrophic osteoarthropathy

NSCLC - non‐small‐cell lung cancer

SCLC - small‐cell lung cancer

Footnotes

The corresponding author has the right to grant on behalf of all authors, and does grant on behalf of all authors an exclusive licence (or non‐exclusive for government employees) on a worldwide basis to the BMJ Publishing Group Ltd to permit this article (if accepted) to be published in ARD and any other BMJPGL products and sublicences such use and exploit all subsidiary rights, as set out in our licence (http://ARD.bmj.com/ifora/licence.pdf).

References

1. Patel A M, Davila D G, Peters S G. Paraneoplastic syndromes associated with lung cancer. Mayo Clin Proc 1993. 68278–287.287 [PubMed]
2. Beckles M A, Spiro S G, Colice G L, Rudd R M. Initial evaluation of the patient with lung cancer. Chest 2003. 12397S–104S.104S [PubMed]
3. Ikeda N, Hayashi A, Miura Y, Okunaka T, Okuzawa K, Tsuboi M. et al Present strategy of lung cancer screening and surgical management. Ann Thorac Cardiovasc Surg 2005. 11363–366.366 [PubMed]
4. The American Thoracic Society and The European Respiratory Society Pretreatment evaluation of non‐small‐cell lung cancer. Am J Resp Crit Care Med 1997. 156320–332.332 [PubMed]
5. Caldwell D S, McCallum R M. Rheumatologic manifestations of cancer. Med Clin North Am 1986. 70385–417.417 [PubMed]
6. Schumacher H R. Articular manifestations of hypertrophic osteoarthropathy in bronchogenic carcinoma. A clinical and pathologic study. Arthritis Rheum 1976. 19629–636.636 [PubMed]
7. Martinez‐Lavin M. Digital clubbing and hypertrophic osteoarthropathy: a unifying hypothesis. J Rheumatol 1987. 146–8.8 [PubMed]
8. Pazzaglia U E, Barbieri D, Cherubino P. Solitary metastasis of the patella as the first manifestation of lung cancer. A case report. Int Orthop 1989. 13179
9. Pauzner R, Istomin V, Segal‐Lieberman G, Matetzky S, Farfel Z. Bilateral patellar metastases as the clinical presentation of bronchogenic adenocarcinoma. J Rheumatol 1996. 23939–941.941 [PubMed]
10. Sun E C, Nelson S D, Seeger L L, Lane J M, Eckardt J J. Patellar metastasis from squamous cell carcinoma of the lung: a case report. Clin Orthop Relat Res 2001. 391234–238.238 [PubMed]
11. Younes M, Hayem G, Brissaud P, Grossin M, Kahn M F, Meyer O. Monoarthritis secondary to joint metastasis. Two case reports and literature review. Joint Bone Spine 2002. 69495–498.498 [PubMed]
12. Ishioka S, Maeda A, Iougasaki Y, Hiyama K, Yamakido M. Psoriatic arthritis complicating lung cancer. Intern Med 2000. 39185–187.187 [PubMed]
13. Bongartz T, Sutton A J, Sweeting M J, Buchan I, Matteson E, Montori V. Anti‐TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies. Systematic review and meta‐analysis of rare harmful effects in randomized controlled trials. JAMA 2006. 2952275–2285.2285 [PubMed]
14. Mountain C F. Revisions in the international system for staging lung cancer. Chest 1997. 1111710–1717.1717 [PubMed]
15. Mery C M, Pappas A N, Burt B M, Bueno R, Linden P A, Sugarbaker D J. et al Diameter of non‐small cell lung cancer correlates with long‐term survival. Chest 2005. 1283255–3260.3260 [PubMed]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group